CRITICAL THERAPEUTIC CRTX (NASDAQd) $ 0.38 Change: -0.02 -5% | Volume: 44,693

CRITICAL THERAPEUTICS - Fundamental Profile

Company Information

Ticker Symbol: CRTX
Exchange: NASD
Contact Info: 60 Westview Street Lexington, MA 02421 (781) 402-5700
CEO/President: Dr. Trevor Phillips, Ph.D.
Industry: Biotechnology / Standard Industry Code: 2834
Description: A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body\'s inflammatory response.

Share Information

Shares Outstanding: 42,805 (000) Market Value: 16,087 ($000)
Percentage of Inst.Shareholders: 27.7% Number of Inst.Shareholders: 25
Last Quarter Sales: 3.3 ($Mil.) Last Quarter Net Income: -10.8 ($Mil.)
Last Quarter EPS: -.25 P/E Ratio: NE
Most Recent Earnings: Earnings Per Share: -1.00
Most Recent Split: Annual Dividend Rate: .00
Most Recent Dividend: Annual Dividend Yield: .0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement